Exostar to Speak, Exhibit, and Moderate Breakout Discussion Session at SCOPE 2021

Exostar to Speak, Exhibit, and Moderate Breakout Discussion Session at SCOPE 2021

Thousands of Clinical Ops Executives Will Gather Virtually to Focus on Advances and Innovative Solutions in All Aspects of Clinical Trial Planning, Management, and Operations

HERNDON, VA, February 24, 2021 – Exostar, the leader in trusted, secure business collaboration in aerospace and defense (A&D), life sciences, and healthcare, will share how clinical trials sites, investigators, and other participants can work more efficiently, effectively, and securely with their pharmaceutical company sponsors at SCOPE 2021, the Summit for Clinical Ops Executives.  The virtual event, with this year’s theme of “Driving Innovation in Clinical Trials & Digital Health,” takes place March 2-4.

As the research and development process for new drugs and therapies becomes increasingly partner-centric, clinical trials site personnel must acquire and manage more digital identities to access systems across multiple trials associated with multiple sponsors.  The COVID-driven remote work environment exacerbates these challenges, raising the urgency to modernize and improve the user experience.

At SCOPE 2021, Exostar’s virtual booth will highlight the company’s Secure Access Manager (SAM) product.  SAM offers a connect-once architecture for organizations to simplify access to applications approved for their trials.  It delivers single sign-on for individuals, allowing them to use one digital identity to reach all of the applications to which they have been granted permission, spanning all trials and sponsors.  Today, SAM serves as the hub for a community of nearly 20,000 life science organizations, 400,000 users, and over 100 applications.

Kenny Kong, Director of Life Sciences & Health IT at Exostar, will deliver a presentation, “The Key to Decentralize Your Trial Is to Centralize Your Technology,” as part of the conference’s Technology/Decentralized Trials and Clinical Innovation track.  He will identify the hurdles posed by decentralized trials, particularly in the COVID era, and explain how unifying access through a single point of entry harnesses technology to promote productivity and keep trials on the fast track.

Exostar’s Senior Director of Life Sciences & Health IT Business Solutions, Tom Johnson, will co-moderate (along with executives from companies including AbbVie, Bayer, and Janssen) an interactive breakout discussion, “From Digital Endpoints to Digital Trials to Digital Healthcare & Back.”  The session brings attendees together to talk about key issues, real-world use cases, and ideas for problem resolution.

Reducing clinical trials site burden remains a top priority, and Exostar continues to lead the way.  Engage with Exostar at SCOPE 2021 to learn more.  Members of the media and analyst community who cover the life science industry can register for a complimentary SCOPE 2021 press pass.

WHO:              Tom Johnson, Senior Director of Life Sciences & Health IT Business Solutions, Exostar

WHAT:            Breakout Discussion – “From Digital Endpoints to Digital Trials to Digital Healthcare & Back”

WHEN:            Tuesday, March 2, 2021, 4:05 PM U.S. ET

WHERE:         SCOPE 2021 Virtual Conference

WHO:              Kenny Kong, Director of Life Sciences & Health IT, Exostar

WHAT:            Presentation – “The Key to Decentralize Your Trial Is to Centralize Your Technology”

WHEN:            Thursday, March 4, 2021, 10:50 AM U.S. ET

WHERE:         SCOPE 2021 Virtual Conference

About Exostar

Exostar’s cloud-based platform creates exclusive communities within highly-regulated industries where organizations securely collaborate, share information, and operate compliantly.  Within these communities, we build trust.  More than 135,000 aerospace and defense organizations and agencies in 175 countries trust Exostar to strengthen security, reduce expenditures, raise productivity, and help them achieve their missions.  Ten of the top twenty global biopharmaceutical companies rely on Exostar to help them speed new medicines and therapies to market.  Exostar is a Gartner Cool Vendor.  For more information, please visit www.exostar.com, and follow Exostar on LinkedIn and Twitter.

Media Contact:

Alan Gilbert
Exostar
(703) 793-7735 (o)

(703) 624-4675 (m)
Alan.Gilbert@exostar.com